Pancreatic Head Malignancy
Pancreatic Head Malignancy - Related Videos
10:10
Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
0 Views •
2026
This protocol presents robotic duodenum-preserving total pancreatic head resection (R-DPPHRt) for intraductal papillary mucinous neoplasms (IPMNs). A video demonstrates the technique in a patient with main duct-IPMN, highlighting its feasibility as a minimally invasive, organ-preserving alternative to pancreaticoduodenectomy.
00:05
Robotic Enucleation of an Intra-Pancreatic Insulinoma in the Pancreatic Head
0 Views •
Cited by 4 •
2020
Here, we present a robotic approach to enucleate an insulinoma in the pancreatic head.
13:38
Robotic Pancreatoduodenectomy for Pancreatic Head Cancer: a Case Report of a Standardized Technique
0 Views •
Cited by 4 •
2022
Robotic pancreatoduodenctomy (RPD) has been highly standardized in recent years and may be used in selected patients with pancreatic head cancer, including those with a replaced right hepatic artery. This case report describes a standardized and reproducible technique for RPD, which includes the approach of the Dutch LAELAPS-3 training program to an aberrant vasculature.
04:12
Acute Biliary Pancreatitis Model: A Method to Generate Acute Biliary Pancreatitis Mouse Model via Pancreatic Duct Infusion
0 Views •
2025
This video describes the procedure for the generation of a mouse model with acute biliary pancreatitis via pancreatic infusion of sodium taurocholate. This model helps study pathophysiological changes induced by sodium taurocholate in the pancreas.
08:32
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
0 Views •
Cited by 9 •
2019
Transgenic lck:eGFP zebrafish express GFP highly in T lymphocytes, and have been used to study T cell development and acute lymphoblastic leukemia. This line can be used to study B cells, which express lck at lower levels. This protocol describes purification of malignant and non-malignant B cells from lck:eGFP zebrafish.
FAQs
Cancer research examines how acquired genetic and regulatory alterations change cellular behavior. These changes can support uncontrolled growth, tissue invasion, and adaptation during disease progression. Studying the relationship between molecular alterations and clinical features may reveal disease mechanisms, identify candidate biomarkers, and indicate why some tumors respond differently to treatment.
The tumor’s position near the duodenum and common bile duct makes local effects especially important. Growth in this region can interfere with biliary or pancreatic duct flow, affecting digestion and contributing to clinically significant obstruction. This anatomical relationship also makes the disease relevant to imaging interpretation and planning potential local interventions.
Therapeutic resistance helps explain why systemic treatment may not produce the same outcome across patients. In pancreatic head malignancy, researchers investigate tumor biology and molecular drivers to understand how malignant cells persist despite treatment. These studies can guide development of improved systemic therapies and help connect laboratory findings with outcomes in localized or advanced disease.
Biomarkers and imaging provide different but complementary types of information. Biomarker research seeks measurable signals that may support earlier recognition, while imaging helps visualize disease and evaluate its anatomical relationships. Combining these approaches can strengthen diagnostic strategies, improve assessment of tumor extent, and provide information relevant to treatment selection and surgical planning.
A research-focused workflow evaluates how molecular findings, biomarker results, and imaging information can be integrated to identify disease and characterize its extent. The goal is not simply to detect a tumor, but to improve diagnostic accuracy and provide clinically useful information for deciding whether localized management or systemic treatment should be considered.
Imaging is important because the tumor arises in an anatomically complex region adjacent to the duodenum and common bile duct. Research uses imaging to clarify the local extent of disease and its effects on nearby structures. That information can support surgical planning by helping clinicians assess the feasibility and scope of local treatment.
Treatment research must account for whether pancreatic head malignancy remains localized or has become advanced. Localized disease raises questions about surgical planning and other regionally focused approaches, whereas advanced disease emphasizes systemic treatment. Comparing these settings helps researchers evaluate appropriate outcomes, understand treatment limitations, and develop strategies suited to different clinical circumstances.
This disease connects several major research areas, including tumor biology, molecular drivers, early detection, imaging, biomarker development, and therapeutic resistance. Because these areas influence diagnosis and treatment together, findings can support more coordinated cancer care. The research also links mechanistic laboratory studies with practical goals such as improved diagnostic strategies and treatment development.